| Serial Number | 90226491 |
| Word Mark | RADX |
| Filing Date | Wednesday, September 30, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 26, 2021 |
| Registration Number | 6534475 |
| Registration Date | Tuesday, October 26, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 10, 2021 |
| Goods and Services | Promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting improvement of clinical laboratory testing technologies for COVID-19 and influenza flu; promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting community-engaged projects to assess and expand availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting community-engaged projects to assess and expand availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting rapid scale-up of testing technologies for pathogens; promoting rapid scale-up of testing technologies for viruses that cause COVID-19 and influenza flu; promoting increased availability of testing technologies for pathogens; promoting increased availability of testing technologies for viruses that cause COVID-19 and influenza flu; administration and management of research grants; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu |
| Goods and Services | Providing grants and financial support for biomedical research and development; providing grants and financial support for biomedical engineering; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for pathogens; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; providing grants and financial support for community-engaged projects, namely, establishment of clinical research sites and testing centers in underserved and/or vulnerable communities; providing information regarding funding opportunities relating to biomedical and scientific research and developments via a website |
| Goods and Services | Providing a website featuring blogs, non-downloadable videos, non-downloadable videocasts, and educational presentations in the nature of seminars, forums, and non-downloadable webinars relating to medical, biomedical and scientific research information and distribution of educational materials in connection therewith |
| Goods and Services | Providing a website featuring medical, biomedical and scientific research information; providing a website featuring news in the field of biomedical and scientific research and developments; providing a website featuring biomedical and scientific research information and developments, namely, dashboards displaying biomedical and scientific research data, information and developments |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | Wednesday, April 29, 2020 |
| First Use In Commerce Date | Wednesday, April 29, 2020 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 036 |
| First Use Anywhere Date | Thursday, April 30, 2020 |
| First Use In Commerce Date | Thursday, April 30, 2020 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 041 |
| First Use Anywhere Date | Sunday, May 31, 2020 |
| First Use In Commerce Date | Sunday, May 31, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, May 31, 2020 |
| First Use In Commerce Date | Sunday, May 31, 2020 |
| Party Name | U.S. Department of Health and Human Services |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Bethesda, MD 20892 |
| Party Name | U.S. Department of Health and Human Services |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Bethesda, MD 20892 |
| Party Name | U.S. Department of Health and Human Services |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Bethesda, MD 20892 |
| Event Date | Event Description |
| Tuesday, October 26, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 10, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 10, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 21, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 21, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 21, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 21, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 25, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 25, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, January 25, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, December 21, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 21, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, December 21, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, December 21, 2020 | ASSIGNED TO EXAMINER |
| Friday, December 18, 2020 | PETITION TO DIRECTOR - GRANTED |
| Thursday, December 17, 2020 | ASSIGNED TO PETITION STAFF |
| Monday, November 16, 2020 | TEAS PETITION TO DIRECTOR RECEIVED |
| Saturday, November 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, October 3, 2020 | NEW APPLICATION ENTERED IN TRAM |